355 related articles for article (PubMed ID: 25884528)
1. Overview of current and alternative therapies for idiopathic membranous nephropathy.
Tran TH; J Hughes G; Greenfeld C; Pham JT
Pharmacotherapy; 2015 Apr; 35(4):396-411. PubMed ID: 25884528
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
[TBL] [Abstract][Full Text] [Related]
3. Management of Membranous Nephropathy in Western Countries.
Alfaadhel T; Cattran D
Kidney Dis (Basel); 2015 Sep; 1(2):126-37. PubMed ID: 27536673
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive treatment of idiopathic membranous nephropathy: the dilemma continues.
Filippone EJ
Clin Nephrol; 2013 Feb; 79(2):143-53. PubMed ID: 23211341
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome.
Chen A; Frank R; Vento S; Crosby V; Chandra M; Gauthier B; Valderrama E; Trachtman H
BMC Nephrol; 2007 Aug; 8():11. PubMed ID: 17683621
[TBL] [Abstract][Full Text] [Related]
6. An overview of immunosuppressive therapy in idiopathic membranous nephropathy.
Maas R; Hofstra JM; Wetzels JF
Minerva Med; 2012 Aug; 103(4):253-66. PubMed ID: 22805618
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil and cyclosporine therapy in membranous nephropathy.
Cattran DC
Semin Nephrol; 2003 May; 23(3):272-7. PubMed ID: 12838495
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
du Buf-Vereijken PW; Branten AJ; Wetzels JF
Am J Kidney Dis; 2005 Dec; 46(6):1012-29. PubMed ID: 16310567
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic membranous nephropathy: diagnosis and treatment.
Fervenza FC; Sethi S; Specks U
Clin J Am Soc Nephrol; 2008 May; 3(3):905-19. PubMed ID: 18235148
[TBL] [Abstract][Full Text] [Related]
10. Comparison of different therapies in high-risk patients with idiopathic membranous nephropathy.
Peng L; Wei SY; Li LT; He YX; Li B
J Formos Med Assoc; 2016 Jan; 115(1):11-8. PubMed ID: 26315481
[TBL] [Abstract][Full Text] [Related]
11. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.
Jha V; Ganguli A; Saha TK; Kohli HS; Sud K; Gupta KL; Joshi K; Sakhuja V
J Am Soc Nephrol; 2007 Jun; 18(6):1899-904. PubMed ID: 17494881
[TBL] [Abstract][Full Text] [Related]
12. Treatment of idiopathic membranous nephropathy.
Hofstra JM; Fervenza FC; Wetzels JF
Nat Rev Nephrol; 2013 Aug; 9(8):443-58. PubMed ID: 23820815
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy.
Liang J; Hao W; Xia F; Zhao Z; Wu Y; Yu F; Hu W; Fang X; Liu W
Ren Fail; 2023 Dec; 45(1):2212081. PubMed ID: 37194712
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis.
Zheng Q; Yang H; Liu W; Sun W; Zhao Q; Zhang X; Jin H; Sun L
BMJ Open; 2019 Sep; 9(9):e030919. PubMed ID: 31511292
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults.
Xie G; Xu J; Ye C; Chen D; Xu C; Yang L; Ma Y; Hu X; Li L; Sun L; Zhao X; Mao Z; Mei C
PLoS One; 2012; 7(9):e44330. PubMed ID: 22957065
[TBL] [Abstract][Full Text] [Related]
16. ACTH and azathioprine: antiproteinuric and lipid-lowering effect in the course of idiopathic membranous glomerulonephritis.
Gigante A; Rosato E; Liberatori M; Gasperini ML; Giannakakis K; Barbano B; Cianci R; Salsano F; Amoroso A
J Biol Regul Homeost Agents; 2012; 26(1):135-8. PubMed ID: 22475105
[TBL] [Abstract][Full Text] [Related]
17. Management of Membranous Nephropathy in Asia.
Xu J; Hu X; Xie J; Chen N
Kidney Dis (Basel); 2015 Sep; 1(2):119-25. PubMed ID: 27536672
[TBL] [Abstract][Full Text] [Related]
18. Early initiation of immunosuppressive treatment in membranous nephropathy patients.
Chan CK; Lai TS; Chen PM; Chou YH; Wu CF; Chiu YL; Chiang WC; Chen YM; Chu TS; Wu KD
J Formos Med Assoc; 2017 Apr; 116(4):266-275. PubMed ID: 28202222
[TBL] [Abstract][Full Text] [Related]
19. [Membranous nephropathy: New insights in therapeutic approach].
Dahan K
Nephrol Ther; 2017 Apr; 13 Suppl 1():S83-S87. PubMed ID: 28577748
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study.
Naumovic R; Jovanovic D; Pavlovic S; Stosovic M; Marinkovic J; Basta-Jovanovic G
Biomed Pharmacother; 2011 Mar; 65(2):105-10. PubMed ID: 21109389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
